EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer

Conditions:   Head and Neck Cancer;   Squamous Cell Carcinoma
Interventions:   Drug: Avelumab;   Drug: Cetuximab
Sponsors:   University College, London;   Merck KGaA
Not yet recruiting

https://ift.tt/2GRbpAD